BioAtla and GATC Health announce $40 million SPV transaction to advance ozuriftamab vedotin into a registrational trial for 2L+ OPSCC: San Diego Saturday, January 3, 2026, 18:00 H ...

Scientists and physicians can better assess precision genome editing technology using a new method made public today by St.

Sionna Therapeutics raised about $191 million in its initial public offering last February. Since then it's made progress with experimental treatments for cystic fibrosis. In June, the company ...

Researchers at the Francis Crick Institute and AlveoliX have developed the first human 'lung-on-chip' model using genetically identical cells derived from stem cells taken from a single donor.The ...

WHO Research Says COVID-19 Still Serious, But Vaccines Offer Strong Protection The COVID-19 story isn’t over yet—though the ...

Xortx Therapeutics announces pioneering research on genome-wide pathogenic pathways in gout: Calgary, Alberta Saturday, January 3, 2026, 13:00 Hrs [IST] Xortx Therapeutics Inc., a ...

There's a warning for Brits ordering weight loss injections such as Mounjaro and Wegovy to take extra care as temperatures plummet.

Vietnam-US relations, marked by a series of major anniversaries and substantive advances across multiple areas of cooperation ...